8月19日，Hims & Hers Health盘中上涨5.26%，报29.01美元/股，成交额1.03亿美元。
消息面上，公司CEO Andrew Dudum当日接受CNBC采访，就此前FTC指控公司向Meta及Snap共享用户健康数据、收费违规及订阅取消障碍等问题进行正面回应。Dudum表示相关指控源于外界对公司商业模式的误解，强调公司是"积极的颠覆者"，核心目标在于扩大医疗服务可及性。此外，CEO在节目中强调公司封闭循环数据构成核心护城河，对行业合作伙伴具有重大价值。管理层积极表态缓解了此前FTC诉讼引发的市场担忧，叠加近期Needham上调目标价至42美元等利好信号，推动股价反弹。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.